Jubilant Ingrevia Ltd.

JUBLINGREA

Market Cap
₹8,576 Cr.
P/E
41.64

Jubilant Ingrevia Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics
Other Income
Other Income is not affecting ratios of the company
Pledge
Promoters have not pledged a significant portion of their holding
Capex vs ROCE
Unable to calculate due to limited data
Revenue Recognition
Company is converting accounting profit to cash
Depreciation Effect
Depreciation accounting is not leading to increase in profits
Contingent Liabilities
Company does not have significant contingent liabilities
Retail Holding
Retail has been selling the stock which is usually a good time to buy
Share price
Share price has increased over last 10 years but more due to rerating
ROE
ROE has decreased vs 10 year trend
Working Capital
Working Capital of the company seems to be under control
Debt
Company should not have issues servicing its debt
Promoter Holding
Promoter has not sold any shares in the last 90 days
Current vs Historic Valuation
Company is trading at a premium to 3 year historic valuations
ROE
Latest
11.53%
3yr Average
11.32%
5yr Average
44.26%
Net Profit Margin
Latest
6.44%
3yr Average
8.01%
5yr Average
6.01%
ROCE
Latest
14.93%
3yr Average
15.33%
5yr Average
47.27%
Debt to Equity
Latest
0.15
3yr Average
0.18
5yr Average
0.13
Market Share
52% (as of Mar 21)
Cetyl Pyridinium Chloride - Market Share
locked Source
26% (as of Mar 21)
Cyanopyridines - Market Share
locked Source
30% (as of Mar 21)
Ethyl Acetate - Market Share
locked Source
70% (as of Mar 21)
Indian Acetic Anhydride - Market Share
locked Source
9% (as of Mar 21)
Life Science Chemicals - Market Share
locked Source
22% (as of Mar 21)
Pyridine and Picolines - Global Market Share
locked Source
10% (as of Mar 21)
Specialty Alcohol - Market Share
locked Source
13% (as of Mar 21)
Specialty Chemicals - Market Share
locked Source
20% (as of Sep 22)
Vitamin B3 - Market Share
locked Source
69% (as of Sep 22)
Vitamin B4 - Market Share
locked Source
Show more
Revenue mix

Segment Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up -Life Science Chemicals

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up -Specialty Chemicals

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up -Nutrition & Health Products

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Verticals

locked
Source
|
Latest
|
locked
Historic

Operating Profit Break-Up

locked
Source
|
Latest
|
locked
Historic

Capex

locked
Source
|
Latest
|
locked
Historic

Asset Break-Up - Segment Wise

locked
Source
|
Latest
|
locked
Historic

Asset Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • Capacity Utilization - Nutrition & Health Solutions (%)
      Source
    • Capacity Utilization - Life Science Chemicals (%)
      Source
    • Capacity Utilization - Speciality Chemicals (%)
      Source
    • Manufacturing Capacity - Speciality Chemicals (MTPA)
      Source
    Peer Comparison
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Jubilant Ingrevia Ltd.
    Jubilant Ingrevia: Discussion with analysts - Trendlyne
    Jubilant Ingrevia vs Laxmi Organics|Discount to fair value?|P2P Analysis - SOIC
    Why Jubilant Ingrevia can be next big growth story? - Prasad Wakchaure
    Business Deep Dive And Why Its Not In Favour Anymore - The Average Trader
    Detailed Analysis Of Jubilant Ingrevia - SOIC
    timeline